-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Purchasing with volume aims to squeeze out the moisture in the sales process, and products within the scope of centralized procurement will bid farewell to the era of high gross profit margins
.
With the advancement of the normalization of centralized procurement, the varieties of consumables in the orthopaedic field with large clinical usage and high purchase amount are constantly being "targeted"
.
Flush iFinD data shows that in 2020, the sales expenses of listed orthopaedic companies accounted for as low as 23.
74% of operating income, and some as high as 47.
6%
.
In terms of gross profit margin, the gross profit margin of orthopedic listed companies is generally above 60%, and some may even be as high as 90%
.
Among high-value medical consumables, the orthopedic implant market is the largest market after vascular intervention
.
According to a report released by the China Business Research Institute, in recent years, the market size of China's orthopedic implanted medical devices has shown an increasing trend year by year
.
Among them, the market size in 2020 has reached 35.
3 billion yuan, and it is expected to continue to grow in the next few years
.
From the perspective of subdivided products, orthopedic implant consumables are mainly divided into three categories: spine, trauma and joint, with a total market share of over 70%
.
Among them, the joint category occupies the main market share, reaching 37%, followed by the spine category (18%) and the trauma category (14%)
.
In September 2021, the results of the national procurement of artificial joints were announced, and the price of artificial joints to be selected was reduced from an average of 30,000 yuan to less than 10,000 yuan, a drop of more than 80%
.
Recently, there is news that the national procurement of the spine has entered the countdown, and the market reshuffle is imminent
.
It is understood that spinal implant consumables are mainly cervical and thoracolumbar internal fixation systems (mainly in the form of nail rods or nail plates) and intervertebral cages, which are used for spinal degenerative diseases, spinal fractures, spinal deformities, tumors and infections.
treatment of spinal diseases
.
Among them, the posterior spinal internal fixation system using pedicle screws and rods accounts for about 70% of domestic spinal surgery
.
In terms of the progress of the centralized procurement of the spine, as early as March 2021, there was news of the centralized procurement of high-value medical consumables for artificial joints, spines, and trauma.
.
On February 11 this year, the National Medical Insurance Bureau stated at a regular policy briefing that the procurement of medical consumables will be further extended to spinal consumables, thereby basically achieving the main coverage of orthopedic consumables
.
At present, a thorough research on spinal consumables is being carried out, as well as information standardization and rule research
.
At the end of March, the joint procurement office of high-value medical consumables organized by the state issued the "Notice on Carrying out Information Confirmation of Orthopedic Spine Medical Consumables"
.
It clearly pointed out that in order to do a good job in the centralized procurement of orthopaedic spinal medical consumables, the state organized the joint procurement office of high-value medical consumables to complete the parts information sorting for spinal consumables, and is now carrying out the confirmation of parts information
.
A few days ago, the "Notice on Carrying out the Historical Purchase Data of Orthopaedic Spine Medical Consumables" issued by the Joint Procurement Office of High Value Medical Consumables of the State Organization shows that in order to do a good job in the centralized procurement of orthopaedic spinal medical consumables, find out the actual situation.
Therefore, the filling and reporting of historical procurement data of orthopedic spinal medical consumables is carried out
.
The data reporting system is open from April 22 to May 10
.
The industry pointed out that this investigation is to provide a certain basis and reference for the later purchase demand
.
From the perspective of industry insiders, with the normalization of the centralized procurement of orthopedic consumables, the price reduction of products has become a trend, and the entire market may be shuffled
.
At present, foreign companies such as Johnson & Johnson and Medtronic occupy more than 50% of the market share in China's orthopaedic implant consumables market.
Among local companies, Weigao Orthopedics and Sanyou Medical have a market share of about 8% and 4% respectively
.
Among them, the spine products of Weigao Orthopedics will account for nearly half of the main business revenue in 2021, and the spine products of Sanyou Medical will account for 87% of the operating revenue
.
The industry believes that with the advancement of centralized procurement, domestic enterprises may accelerate the pace of import substitution
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
With the advancement of the normalization of centralized procurement, the varieties of consumables in the orthopaedic field with large clinical usage and high purchase amount are constantly being "targeted"
.
Flush iFinD data shows that in 2020, the sales expenses of listed orthopaedic companies accounted for as low as 23.
74% of operating income, and some as high as 47.
6%
.
In terms of gross profit margin, the gross profit margin of orthopedic listed companies is generally above 60%, and some may even be as high as 90%
.
Among high-value medical consumables, the orthopedic implant market is the largest market after vascular intervention
.
According to a report released by the China Business Research Institute, in recent years, the market size of China's orthopedic implanted medical devices has shown an increasing trend year by year
.
Among them, the market size in 2020 has reached 35.
3 billion yuan, and it is expected to continue to grow in the next few years
.
From the perspective of subdivided products, orthopedic implant consumables are mainly divided into three categories: spine, trauma and joint, with a total market share of over 70%
.
Among them, the joint category occupies the main market share, reaching 37%, followed by the spine category (18%) and the trauma category (14%)
.
In September 2021, the results of the national procurement of artificial joints were announced, and the price of artificial joints to be selected was reduced from an average of 30,000 yuan to less than 10,000 yuan, a drop of more than 80%
.
Recently, there is news that the national procurement of the spine has entered the countdown, and the market reshuffle is imminent
.
It is understood that spinal implant consumables are mainly cervical and thoracolumbar internal fixation systems (mainly in the form of nail rods or nail plates) and intervertebral cages, which are used for spinal degenerative diseases, spinal fractures, spinal deformities, tumors and infections.
treatment of spinal diseases
.
Among them, the posterior spinal internal fixation system using pedicle screws and rods accounts for about 70% of domestic spinal surgery
.
In terms of the progress of the centralized procurement of the spine, as early as March 2021, there was news of the centralized procurement of high-value medical consumables for artificial joints, spines, and trauma.
.
On February 11 this year, the National Medical Insurance Bureau stated at a regular policy briefing that the procurement of medical consumables will be further extended to spinal consumables, thereby basically achieving the main coverage of orthopedic consumables
.
At present, a thorough research on spinal consumables is being carried out, as well as information standardization and rule research
.
At the end of March, the joint procurement office of high-value medical consumables organized by the state issued the "Notice on Carrying out Information Confirmation of Orthopedic Spine Medical Consumables"
.
It clearly pointed out that in order to do a good job in the centralized procurement of orthopaedic spinal medical consumables, the state organized the joint procurement office of high-value medical consumables to complete the parts information sorting for spinal consumables, and is now carrying out the confirmation of parts information
.
A few days ago, the "Notice on Carrying out the Historical Purchase Data of Orthopaedic Spine Medical Consumables" issued by the Joint Procurement Office of High Value Medical Consumables of the State Organization shows that in order to do a good job in the centralized procurement of orthopaedic spinal medical consumables, find out the actual situation.
Therefore, the filling and reporting of historical procurement data of orthopedic spinal medical consumables is carried out
.
The data reporting system is open from April 22 to May 10
.
The industry pointed out that this investigation is to provide a certain basis and reference for the later purchase demand
.
From the perspective of industry insiders, with the normalization of the centralized procurement of orthopedic consumables, the price reduction of products has become a trend, and the entire market may be shuffled
.
At present, foreign companies such as Johnson & Johnson and Medtronic occupy more than 50% of the market share in China's orthopaedic implant consumables market.
Among local companies, Weigao Orthopedics and Sanyou Medical have a market share of about 8% and 4% respectively
.
Among them, the spine products of Weigao Orthopedics will account for nearly half of the main business revenue in 2021, and the spine products of Sanyou Medical will account for 87% of the operating revenue
.
The industry believes that with the advancement of centralized procurement, domestic enterprises may accelerate the pace of import substitution
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
